NAGE - Pendapatan operasional sadurunge ngurangi amortisasi Niagen

Logo perusahaan publik ChromaDex Corp (NAGE)

The EBITDA of Chromadex Corp (NAGE) reflects cash flow dynamics, where the current parameter equals 4.84. Growth is constrained by strict FDA oversight regarding Tru Niagen marketing. However, Niagen patents ensure leadership in cellular energy. A steady inflow of funds is guaranteed by a recurring sales model for dietary supplements via online channels and retail.

niagenbioscience.com (NAGE) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi saka 23.11.2025 nganti 11.11.2026

Ringkesan rincian data analitis ChromaDex Corp (NAGE)

Pambiji fundamental perusahaan:NAGE (Chromadex Corp)
Sampel barang ChromaDex Corp

This indicator reflects the actual cash inflow from core operations before deducting interest expenses. The metric eliminates reporting time lags, capturing the daily operational efficiency of the business. Analyzing EBITDA fluctuations allows for tracking real-time cash flow dynamics between quarterly reports. For Chromadex Corp (NAGE), this confirms financial stability during the commercialization of patented dietary supplements. High liquidity here is based on deep consumer trust in science-intensive products.

Pesaing Chromadex Corp (NAGE)

Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ISRG|Danaher Corp. - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi bd.com BDX|STERIS (STE) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi WST|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Baxter Corp|Masimo Inc. (MASI) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi STVN (Stevanato Group S.p.A.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TFX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Merit Medical MMSI|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NVST|ICUI: Bathi operasional sadurunge ngurangi amortisasi|XRAY - Bathi operasional EBITDA|LeMaitre Vascular, Inc. (LMAT) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi atricure.com|STAA (STAAR Surgical) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi ZimVie Inc ZIMV|Bathi sadurunge mbayar bunga, pajak, lan amortisasi AngioDynamics Corp (ANGO)|Cerus Inc - Bathi operasional sadurunge amortisasi|Alpha Teknova, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MGRM (monogramorthopedics.com)|STSS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi InfuSystem Holdings INFU|UTMD: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi KORU Medical|NYXH (Nyxoah S.A.) - Bathi operasional EBITDA|MBOT: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pro-Dex (PDEX)|ZTEK (Zentek Ltd) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elutia Corp ELUT|Milestone Scientific Corporation (MLSS) - Bathi sadurunge bunga, pajak, lan amortisasi|NXGL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Retractable Technologies (RVP) - Bathi operasional sadurunge ngurangi amortisasi|HBIO: Bathi operasional EBITDA|Femasys Inc (FEMY) - Bathi operasional EBITDA|MHUA (Meihua Medical Technologies) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi POAI (Predictive Oncology Corp)|Bathi operasional EBITDA CJMB|ATRI - Bathi sadurunge bunga, pajak, lan amortisasi|NeuroMetrix - Bathi operasional sadurunge ngurangi amortisasi